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Abstract: For many research aspects on small non-coding RNAs, especially microRNAs, computational
tools and databases are developed. This includes quantification of miRNAs, piRNAs, tRNAs and
tRNA fragments, circRNAs and others. Furthermore, the prediction of new miRNAs, isomiRs,
arm switch events, target and target pathway prediction and miRNA pathway enrichment are common
tasks. Additionally, databases and resources containing expression profiles, e.g., from different
tissues, organs or cell types, are generated. This information in turn leads to improved miRNA
repositories. While most of the respective tools are implemented in a species-independent manner,
we focused on tools for human small non-coding RNAs. This includes four aspects: (1) miRNA
analysis tools (2) databases on miRNAs and variations thereof (3) databases on expression profiles
(4) miRNA helper tools facilitating frequent tasks such as naming conversion or reporter assay
design. Although dependencies between the tools exist and several tools are jointly used in studies,
the interoperability is limited. We present HumiR, a joint web presence for our tools. HumiR facilitates
an entry in the world of miRNA research, supports the selection of the right tool for a research
task and represents the very first step towards a fully integrated knowledge-base for human small
non-coding RNA research. We demonstrate the utility of HumiR by performing a very comprehensive
analysis of Alzheimer’s miRNAs.
Keywords: microRNAs; bioinformatics; web servers; non-coding RNA; bioinformatics
1. Introduction
In almost all organisms, bacteria, viruses, plants, animals and mammals, research on small
non-coding RNA is performed. Among the different classes of small non-coding RNAs, microRNAs
(miRNAs) are among the best studied ones. The current state-of-the-art on miRNA research has been
published by Bartel in 2018 [1].
Modern high throughput approaches, most importantly massively parallel sequencing, are applied
to generate steadily increasing data sets. A search in the sequence read archive (SRA), one of the
most frequent repositories for small RNA sequencing data, yields 95,015 data sets. The following
list of organisms is covered by over 1000 samples deposited in SRA: Homo sapiens (46,007 samples);
Mus musculus (15,758 samples); Rattus norvegicus (2534 samples); Bos taurus (2307 samples);
Arabidopsis thaliana (1683 samples); Sus scrofa (1328 samples);
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Drosophila melanogaster (1130 samples); Caenorhabditis elegans (1120 samples). Altogether, 115 TB of
sequencing data on small RNAs are deposited in SRA, covering 2 × 1012 reads.
The flood of data calls for advanced computational solutions. Chen and co-workers curated
95 review papers covering about 1000 miRNA bioinformatics tools [2]. A great repository that collects
an overview of many different miRNA tools from a broad range of applications is Tools4miRs [3].
Although many of the tools are independent of the organism or support several organisms, a certain
focus on Homo Sapiens can be recognized. This is motivated by the fact that most and the largest data
sets are available for humans as sketched above. The set of tools includes, but is not necessarily limited
to, approaches for quantifying miRNAs and other non-coding RNAs, prediction of new representatives
from the classes, discovery of isomiRs and other isoforms, prediction of targets and target pathways
or the discovery of arm shift and arm switch events. From miRNA research in general, especially,
however, from the ever-growing data sets and the new tools, databases on miRNAs are built.
The most prominent and referenced database is the miRBase [4,5] but other databases have also
been developed to complement miRBase (MirGeneDB [6] or miRCarta [7] as summarized in [8]).
Currently, it is estimated that around 2300 human miRNAs exist that are yet not completely contained
in these data bases [9]. In addition to databases with a focus on miRNAs, other resources contain
information on predicted or validated targets, variants in miRNAs, isoforms or other structural
features. In addition to respective databases, data warehouses have also been generated as resources
for miRNA expression patterns, including expression profiles for different organs, tissues, cell types
and other specimen types. Here, we do not want to provide anything close to a complete overview of
available tools and databases. These can be found in one of the many excellent review articles and tool
comparisons on the different topics [2,10–19].
Over the past decade we have implemented tools and resources that are dedicated to foster the
analysis and understanding of miRNAs. The joint paradigm of all solutions is in that they must be
available as a web service and not require any installation of client-side software. For these tools,
the focus has been on Homo sapiens. A limitation of the tools is their very limited interoperability.
For example, one tool might generate an output that can directly be processed by another tool.
Frequently, researches might benefit, however, not even being aware that an interesting downstream
processing tool or data base with relevant information exists. It is our ambition to strengthen the
interoperability and provide better access to the tools and data warehouses. As a first step, we wrapped
all web services and databases in docker containers. With the ongoing update of the respective
solutions, we start to introduce a growing set of RESTful Application Programming Interface. The final
result is anticipated to be a central knowledge base and resource for human miRNA research. Here we
introduce HumiR, a web presence that puts the different resources in context, describe the different
resources and facilitates the selection of the right tools for users. Notably, we also do not intend to
benchmark a study and compare it to competing or complementary tools. This is done within the
respective original and updated manuscripts. In contrast, we emphasize that alternative solutions
exist that may even have advantages when compared to our tool. A great example is our miRNA
pathway enrichment tool miEAA [20] where we explicitly notify users to also test their results with the
TAM tool developed in the Cui lab [21]. Of course, we mention selected alternatives to our tools in the
respective sections below. The focus of this work is thus more to present the tools in context to each
other towards a fully integrated solution.
In the following, we will first group the tools into four main categories: (1) miRNA analysis tools
(miRMaster [22], miEAA [20], miRTargetLink, miRSwitch, novoMiRank); (2) databases on miRNAs
and variations thereof (miRCarta, miRSNPdb, miRPathDB, miRATbase); (3) databases on expression
profiles of miRNAs (TissueAtlas, CellTypeAtlas, ATmiRes); (4) miRNA helper tools facilitating frequent
tasks, such as miRNA naming conversion or reporter assay design (miRTaH, miRBaseConverter,
miBlast). In each category we will briefly describe the task of the tools and databases. In the second
section, we will introduce the HumiR resource and how it can be used by researchers. In the third
section, we will then describe dependencies between the tools and exemplify workflows through the
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different tools. Finally, we will provide an outlook on how we will further improve and automate the
interoperability of the tools via APIs towards a fully integrated knowledge base.
2. Experiments and Methods
We implemented HumiR, a web presence as entry point to human miRNA research (https:
//www.ccb.uni-saarland.de/humir/). The web server was implemented using a dockerized version of
Django Web Framework (v2.2) running on Python 3.7. The frontend user-interface was built using
ReactJS (v16.13) and the Material-UI (v4.9) framework, and bundled by Webpack (v4.25). An Nginx
docker container is acting as proxy server in front of the Gunicorn WSGI HTTP server (19.8) providing
access to the Django application. The HumiR web interface has been tested with the following browsers:
Firefox (version 82.0.3), Safari (version 13.1.1), Google Chrome (Version 87.0.4280.67). The availability
of HumiR is monitored on a daily basis by automated API testing.
3. Results
3.1. The Four Categories of Tools
The first set of tools take either high throughput data directly (fastq) or sets of miRNAs as input
to process them. While many of the tools also support an analysis of single miRNAs, the actual key
criterion is the processing of large data sets. The second set of tools relates to databases that contain
information on miRNA sequences or variations thereof, target and target pathway databases. The third
set are databases that host expression profiles on miRNAs. Finally, the last set of tools are small helper
tools that facilitate important tasks quickly. The tools are shown in context to each other in Figure 1
and summarized in Table 1.
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produces another filetype as output, which in turn is again used as input for the next tool. 
3.2. miRNA Analysis Tools 
miRMaster [22,23]: miRMaster is an all-in-one tool for the analysis of raw sequencing data stored 
in fastq files. The files are compressed client-side in javascript, uploaded and then processed. The tool 
is tailored for Illumina and BGI/MGISEQ data and also supports samples with unique molecular 
identifiers as, for example, are implemented in the latest template switch protocols [24]. miRMaster 
quantifies known miRNAs, miRNAs, tRNAs and other small RNAs, has its own prediction engine 
for new miRNAs, maps the data to viruses and bacteria, detects isoforms and reports SNVs in 
miRNAs. Importantly, case control analyses are also supported and differentially expressed features 
are reported. As of October 2020, over 1400 studies have been performed with miRMaster and almost 
Figure 1. The four classes of tools as well as the respective tools. The middle of the figure presents
the different file types, input or output types for the tools. Orange arrows denote a tool input,
e.g., NovoMiRank only works with *.gff files. Orange arrows denote an output of a tool. Theoretically,
walks through this graph can be generated, following this scheme: a tool gets a file type as input and
produces another filetype as output, which in turn is again used as input for the next tool.
3.2. miRNA Analysis Tools
miRMaster [22,23]: miRMaster is an all-in-one tool for the analysis of raw sequencing data
stored in fastq files. The files are compressed client-side in javascript, uploaded and then processed.
The tool is tailored for Illumina and BGI/MGISEQ data and also supports samples with unique
molecular identifiers as, for example, are implemented in the latest template switch protocols [24].
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miRMaster quantifies known miRNAs, miRNAs, tRNAs and other small RNAs, has its own prediction
engine for new miRNAs, maps the data to viruses and bacteria, detects isoforms and reports SNVs in
miRNAs. Importantly, case control analyses are also supported and differentially expressed features
are reported. As of October 2020, over 1400 studies have been performed with miRMaster and almost
100,000 samples (50,000 unique samples) have been processed covering a total of 1.3 trillion reads
(600 Billion unique reads). Alternative tools include among others sRNAbench [25], CPSS2 [26] or
CBS-mirSeq [27].
miEAA [20,28]: miEAA is a miRNA enrichment tool. It works conceptually similar to gene
set enrichment analysis originally introduced by Subramanian [29]. The tool expects either a list of
miRNAs or a set of miRNAs which is then compared to a reference set. In the first case, the unweighted
GSEA is performed with an exact computation of p-values [30]. In the second case the hypergeometric
distribution is computed to get a p-value. miEAA hosts over 15,000 different functional categories and
outputs graphics and tables detailing the pathway enrichment scores. A comprehensive alternative to
miEAA is the TAM tool developed by the Cui lab [21].
miRTargetLink [31]: miRTargetLink takes either a single miRNA, a single gene, a set of miRNAs
or a set of genes and computes from there the miRNA-target network containing all participants
provided by the user. Predicted targets, targets with weak evidence such as microarrays or targets
with stronger evidence such as reporter assays can be chosen between. Alternatives to miRTargetLink
include miRNet 2.0 [32] or miRViz [33].
miRSwitch [34]: miRSwitch is a tool that takes miRNA expression data and from there computes
whether miRNAs perform a shift or switch in terms of the dominant arm. It also offers a comprehensive
background knowledge base that, e.g., hosts arm switch events between different tissues. The input to
miRSwitch is a miRNA expression matrix, but if only the knowledge base is queried a single miRNA
may, of course, also be used as input.
NovoMiRank [35]: Tools such as miRMaster often deliver long sets of potential novel miRNAs.
However, many of these are likely false positives that are introduced, e.g., by library prep bias,
low quality samples or computational artifacts [36,37]. To this end, we implemented NovoMiRank.
The tool takes new miRNA candidates as a gff file and computes for each miRNA the likelihood of
being either a true or false positive.
3.3. Qualitative miRNA Data Bases
miRCarta [7]: miRCarta is a data base that has the ambition to store not only all current miRNAs,
but also all potential candidates in that it is a very sensitive complementation to the very specific and
highly curated miRGeneDB [38]. miRCarta stores miRNAs and miRNA candidates, offers an organism
independent nomenclature that is unambiguous and bears many additional features such as targets,
miRNA families and others. miRCarta can be queried by using any standard miRNA ID, or a gff3 file
can be uploaded and processed. Another alternative to miRCarta and miRGeneDB is the reference
database miRBase [4,5,39].
miRSNPdb [10]: miRSNPdb is a database of predicted miRNA-target interactions, in which we
have assessed all SNPs which may occur in mature miRNAs and/or their target regions, and have
predicted any target gains or losses due to these SNPs. As input, users can provide a miRNA ID,
a gene, or a rs ID representing a SNP. Furthermore, users can also upload VCF files as generated in
typical DNA sequencing studies to perform a batch analysis. Alternatives are, e.g., miRSNP [40] or
PolymiRTS [41]
miRPathDB [42–44]: The miRNA target pathway dictionary that has led to the development of
miRpathDB is a resource for storing target pathways of miRNAs. In brief, for each miRNA different
target sets, strong evidence, weak evidence and predicted targets are pre-computed by GeneTrail [45].
Currently, the database hosts dozens of millions of respective miRNA to target pathway associations.
Users can query the database by entering a miRNA identifier. Moreover, sets of miRNAs can be
provided and heat maps are generated that show which pathways are targeted by those miRNAs.
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As a final feature, a maximal coverage analysis via integer linear programming has been introduced.
Users determine a maximum number of miRNAs and provide a gene set and the tool computes the
minimal number of miRNAs targeting the maximal number of genes provided.
miRATbase: miRATbase is our approach to complement the purely in silico database miRPathDB
with fully validated experimental target pathways of single miRNAs. The idea is that each gene
targeted by a miRNA and on the respective pathway is validated by a reporter assay approach,
in that miRATbase also contains a comprehensive database with results validating miRNA gene
interactions by luciferase assays. Of course, there exist substantially larger databases miRTarBase,
for example, [46] contains a factor more of miRNA gene interactions. There are two differences however.
The first one is that for single miRNAs, we provide a very large numbers of targets that are generated in
a highly standardized manner. The average of miRNA gene interactions per manuscript contained in
the miRTarBase is only 1.6. The second point is the availability of negative interactions. While only 3%
of all reported miRTarBase reporter assays are negative, we include all negative validation experiments.
This makes the data sets of high value for researchers that want to validate their tools.
3.4. Quantitative miRNA Data Bases
TissueAtlas [47]: The miRNA tissue atlas is a repository that hosts expression profiles of miRNAs
across more than 30 organs and tissues. A unique point is that the organs have largely been collected
from the same bodies, excluding inter-individual variations. Researchers can query the atlas by
entering any miRNA identifier and get back different expression statistics that can be interactively
adjusted. While the TissueAtlas has become our most cited miRNA resource, the current version is still
limited to microarray data. The next release will rely on more tissues, more bodies and a much deeper
insight in that we use next-generation sequencing as the experimental technique.
CellTypeAtlas [48,49]: Similar to the TissueAtlas we also generated a resource for miRNA
expression in different blood cell types. Again, researchers can query the resource by entering any
miRNA identifier. In addition to the different cell types, an important factor is the influence of
the purification techniques. MiRNA profiles also vary depending on whether positive selection,
negative selection or FACS sorting has been used.
ATmiRes [50]: We also developed a resource that investigates miRNA expression patterns in
ancient specimens. The most relevant being, of course, miRNA patterns in solid tissue biopsies of the
Tyrolean Iceman. While these patterns that still indicate a certain organ specificity are of limited value
for actual research questions, they nonetheless demonstrate that selected miRNAs are highly conserved.
3.5. miRNA Helper Tools
miRTaH: In our research, we recognized that one time-consuming task is to design constructs for
reporter assays. An analysis of the miRTarBase shows that around 6000 manuscripts report, on average,
1.6 validated target genes by reporter assays. We thus anticipated a need of others for automated
reporter assay design. As a result, we developed the miRNA Target Assay Helper miRTaH.
miRBaseConverter: Another time intensive task is to map identifiers between different miRBase
versions. We thus developed a tool for the batch conversion. A list of miRNA ids is provided as input,
original and desired output version are given and the mapped ids are returned. This is, e.g., of immense
help if an experiment with a microarray using V20 of the miRBase has been carried out and a certain
tool requires version 18 as input.
miBlast: Finally, another task is to understand whether a small piece of RNA, e.g., predicted from
small RNA sequencing results, has already been reported as a miRNA. We thus developed miBlast.
Here, you can enter a sequence or a set of sequences and as output you get the respective hits
from miRCarta.
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3.6. The HumiR Web Presence
As sketched in the introduction our long-term vision is an integrated knowledge base and
analysis workflow for human miRNAs. We detail our vision in the fourth section. As a very
first step towards this challenging goal, we developed the HumiR web presence available at https:
//www.ccb.uni-saarland.de/humir/. Here, we collect the tools that we mention in the present work in
the respective four categories. It is thought to provide an overview on the available tools for researchers
and should serve as an entry point in database queries or for running analysis tasks. To facilitate the
selection of the available tools for a given data type we provide all potential input types on top of the
HumiR web presence. These include single miRNAs, sets of miRNAs, Lists of miRNAs, GFF files,
VCF files and fastq files. The user selects his data type by clicking the icon and all tools that support
this input type are highlighted while all other tools are disabled. If single miRNAs are provided as
the input type, all data bases and tools besides miEAA, miRMaster and NovoMiRank are available.
For fastq, only miRMaster is available, since currently miRMaster is the only tool that works on
fastq files directly. In addition, the web presence contains descriptions of the tools and other useful
information. The web interface of HumiR is presented in Figure 2.
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Figure 2. One walk and workflow. Taking the setup from Figure 1, an example workflow is presented.
The thickness of the arrow represents the steps in the workflow. Starting from a fastq file miRMaster
is used to predict new miRNAs. From these new miRNAs a *.gff file is extracted and used to score
the most likely true positive miRNAs. Those most likely true positive miRNAs can be checked for
consistency with miRCarta and the consistent miRNAs from miRCarta can then be checked with respect
to their expression profiles, or target pathways can be evaluated. Pathway enrichment using miEAA is
also evaluated.
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Table 1. Tool overview.
Category Tool Reference Organism ncRNA Class Brief Description/Link
Analysis
miRMaster [22,23] human miRNA, piRNA, tRNA(+5 others)
non-coding RNA analysis from fastq sequencing files
https://www.ccb.uni-saarland.de/mirmaster
miEAA [20,28] human, mouse, rat (+7 others) miRNA miRNA pathway analysishttps://www.ccb.uni-saarland.de/mieaa
miRTarget Link [31] human miRNA analysis of miRNAs and genes in networkshttps://www.ccb.uni-saarland.de/mirtargetlink
miRSwitch [34] human miRNA analysis of arm switch and shift eventshttps://www.ccb.uni-saarland.de/mirswitch
NovoMiRank [35] human miRNA ranking of novel miRNA candidateshttps://www.ccb.uni-saarland.de/novomirank
Database
miRCarta [7] all from miRBase miRNA comprehensive collection of miRNAs and miRNA candidateshttps://www.ccb.uni-saarland.de/mircarta
miRSNPdb [10] human miRNA mutations in human miRNAshttps://www.ccb.uni-saarland.de/mirsnp
miRPathDB [42–44] human, mouse miRNA target pathways and categories of miRNAshttps://mpd.bioinf.uni-sb.de
miRATbase NA human miRNA positive and negative reporter assay target validationshttps://www.ccb.uni-saarland.de/miratbase
TissueAtlas [47] human, rat miRNA comprehensive atlas of miRNA expression in multiple organshttps://www.ccb.uni-saarland.de/tissueatlas
CellTypeAtlas [48,49] human miRNA comprehensive atlas of miRNA expression in multiple blood cell typeshttps://www.ccb.uni-saarland.de/cf
ATmiRes [50] human miRNA comprehensive atlas of miRNA expression in ancient sampleshttps://www.ccb.uni-saarland.de/atmires
Helper
miRTaH NA all miRNA a tool for designing miRNA reporter assay experimentshttps://www.ccb.uni-saarland.de/mirtah
miRBase
Converter [20,28] all from miRBase miRNA
converts miRNA identifiers between arbitrary miRBase versions
https://www.ccb.uni-saarland.de/mieaa/mirna_version_converter
miBlast [7] all from miRBase miRNA searches potential novel miRNAs in the miRCarta databasehttps://www.ccb.uni-saarland.de/mircarta/miblast
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3.7. Dependencies and Workflows
Dependencies and integration between the tools already exists. For example, if a miRTargetLink
analysis has been done, the pathway enrichment can be directly instantiated from the results page,
making use of the existing API. Another example is the information on target pathways of miRNA
candidates from miRCarta. The most recent version of the pathway database notably also contains
pre-computed target pathways for all candidates in miRCarta that are not contained in miRBase.
Furthermore, if a miRMaster analysis has been completed, users can immediately carry out a miEAA
enrichment analysis from the results tab showing the quantification of miRNAs. One last example
is the TissueAtlas. For comparison, the user can select data to display from the ancient tissues
directly besides the modern tissues by integrating AtmiRes. These represent limited efforts for a
more integrated solution using APIs for the integration of the data. A list of potential associations
that can be used to build comprehensive workflows is presented in Supplementary Materials Table
S1. Here, for 33 combinations, the tools that can be used to build workflows are presented. Notably,
other associations that might be reasonable and possible not included in this table exist.
Let us evaluate a typical workflow. A user might have carried out a small RNA sequencing study on
case and control samples. The first and straightforward step is to perform an analysis using miRMaster.
As result the user gets a list of novel miRNAs. He can upload a respective gff file to NovoMiRank and
exclude likely false positives. Next, he can search for the remaining candidates in miRCarta and knows
whether they have been reported before. He also can directly extract targets and target pathways of
those novel miRNAs. From the set of deregulated miRNAs, he can compute enriched or depleted
functional categories directly from the miRMaster results page and having identified promising
candidates, he can check which organs these are expressed in. This example workflow is presented in
Figure 3. While all these single steps each take a few minutes, they require in total still a relevant amount
of time. Further, many copy and paste or download actions are required. This currently limits taking
full advantage of the different tools and databases. Nonetheless we provide the results of the analyses
showing how much insights can be generated with minimal time. First, we executed miRMaster on the
example data set of 70 Alzheimer’s cases and controls and downloaded all results files (117 files and
536 MB data). miRMaster computed 1605 expressed miRNAs from miRBase along with their p-values
between Alzheimer’s disease (AD) and control. For the highly significant miRNAs (59 miRNAs;
p < 0.005) we performed a standard miEAA analysis using all pathways and categories and downloaded
the results. From the far over 10,000 categories, 901 remained significant in the analysis with the
three most significant: “Alzheimers Disease Dysregulated” (p = 6.2 × 10−27), “Alzheimers Disease
Downregulated” (p = 2.5 × 10−17) and “neuromyelitis optica” (p = 2.1 × 10−14). The next categories
were a seed family (GCAAAG; p = 8.6 × 10−8) followed by the category “Alzheimers Disease” from
MNDR (p = 3.3 × 10−8). This enrichment clearly validated that we indeed found relevant AD miRNAs
in our study, most significantly hsa-miR-1468-5p; hsa-miR-144-5p; hsa-miR-3127-3p; hsa-miR-4781-3p;
hsa-miR-6505-3p; hsa-miR-144-3p; hsa-miR-190a-5p; hsa-miR-26b-3p; hsa-miR-101-3p; hsa-miR-628-3p.
Those we checked in the miRNA tissue atlas. While most miRNAs were found in the vein or in blood
cells, several of those miRNAs were also expressed in the brain or related entities, e.g., miR-144-3p in
the dura mater, hsa-miR-190a-5p in the brain and the dura mater, hsa-miR-26b-3p in the arachnoid
mater, hsa-miR-101-3p in the brain, arachnoid mater and dura mater or hsa-miR-628-3p in the brain.
Respective brain miRNAs might have a higher chance to be functionally related to the disease.
A miRTargetLink analysis of the 59 miRNAs identified one core network consisting of 13 miRNAs,
38 target genes and 86 regulatory events between the miRNAs and target genes, among them APP,
regulated by the brain miRNA hsa-miR-101-3p and hsa-miR-15a-5p. We next asked how many of the
new miRNA candidates from this study have been previously reported and are stored in miRCarta. Of
8982 miRNA candidates reported in that study, 4661 (52%) are actually no new miRNA candidates but
are already stored in miRCarta. Finally, we also checked which miRNAs perform arm shifts between
case and control. To this end, the miRMaster output was directly transferred to miRSwitch. The analysis
identified four miRNAs that vary in their arm usage between AD and control, three with dominant-3p
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arm (hsa-mir-17, hsa-mir-130b and hsa-mir-3200) and one with dominant -5p arm (hsa-let7d). Using a
set of our tools we demonstrated how different tools can be integrated to achieve comprehensive
results for a miRNA case-control sequencing study.Biomolecules 2020, 10, x FOR PEER REVIEW 9 of 12 
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integrated knowledge base and analysis resource of human small non-coding RNAs. With each 
update of a tool or database we now introduce a comprehensive RESTful API. This API describes the 
interfaces that are sketched in Figure 1 but are so flexible that they can be easily extended. Once 
available, HumiR will be updated by the integrated version. Our ambition is that users only provide 
their data. Reasonable workflows for the analysis of these data are automatically generated and 
proposed to the user. Before they are executed, they can be customized. All results of the different 
tools are then aggregated in one central place. This facilitates the simplest analyses (entering one 
single human miRNA and get all information related to this miRNA) up to very complex question 
such as “Which target pathways of a yet unknown miRNA are differentially expressed between cases 
and controls?” supported. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Table S1: A list of 
potential associations that can be used to build comprehensive workflows. 
The Chair for Clinical Bioinformatics at Saarland University has developed numerous tools to aid microRNA  researchers. HumiR is here to match you with the perfect tool
for all your miRNA analysis needs.
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Figure 3. Web presence of HumiR. Screenshot of the web interface of HumiR. Users can select
their input or output file types and all respective tools are enabled while all others are disabled.
Although currently the workflows must be executed manually, the aim of HumiR is a fully integrated
workflow management of all tools.
4. Outlook: The HumiR Knowledge Base
The previous analysis example demonstrated that a time efficient analysis of human small RNA
sequencing data is well feasible with our tool collection. Few examples of direct and deep integration
already demonstrate that the process can be further improved. The disadvantage still remains, we had
to download and upload again many files between the different tools, calling for a fully integrated
knowledge base and analysis resource of human small non-coding RNAs. With each update of a
tool or database we now introduce a comprehensive RESTful API. his PI describes the interfaces
that a e sketched in Figur 1 but are so flexibl that they can be easily ext nded. O c available,
HumiR will be updated by the integrated ve sion. Our ambition is that users only provide their
da a. Reasonable workflo s for the analysis of the e data are automatically generated and proposed
to the u r. Before they are ex cuted, they can be ustomized. All results of the different tools
are then aggregated in one central place. This facilitates the simplest analyses (entering one single
human miRNA and get all information related to this miRNA) up to very complex question such as
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“Which target pathways of a yet unknown miRNA are differentially expressed between cases and
controls?” supported.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/10/11/1576/s1,
Table S1: A list of potential associations that can be used to build comprehensive workflows.
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